HIV/AIDS Prevention and Care
The HIV/AIDS Prevention and Care project aims to strengthen a coordinated South Sudan response to HIV/AIDS by building capacity at the Central, State and County levels, and supporting the scale up of comprehensive HIV/AIDS services. The major objectives are to:
- Improve knowledge and practice of HIV and Sexually Transmitted Infections (STI) preventative measures by the general adult population, youth and vulnerable population subgroups during 2005-2010
- Develop and expand treatment, and care and support services for people and families living with HIV/AIDS
- Build the capacity of the South Sudan HIV/AIDS Commission (SSAC), NGOs and local institutions to effectively manage and monitor HIV/AIDS programmes.
The previous project ended on 30 November 2011 after five (5) years and four (4) months of implementation. From 1 December 2013, the project implementation activities are under the Continuity of Services (COS) for essential services and lifelong treatment such as Antiretroviral Treatment (ART) and Prevention of Mother to Child Transmission (PMTCT). In 2014, the project will continue focusing on implementing activities for Transitional Funding Mechanism to support people and families living with HIV/AIDS.
- 68 health workers were trained on Prevention of Mother to Child Transmission(PMTCT) (14 PMTCT mentors, 32 training of trainers on PMTCT and 22 on PMTCT for health workers)
- 369 HIV exposed infants were supported through the 37 PMTCT sites.
- 15 mother-to-mother support groups were established and supported.
- One Early Infant Diagnosis referral system was established.
- Behavioural change communication activities were implemented by UNICEF for social mobilization activity at outreach level. UNDP is the principal recipient of Global Fund resources under which the activity was implemented by UNICEF.
- Three Sub- Recipients (SRs) were supported for PMTCT activities and two SRs were supported for Anti-Retroviral Therapy (ART) services.
- Drugs and pharmaceutical consumables were procured and distributed to the 22 ART sites.
- The maintenance and onsite refresher training for CD4/haematology/Chemistry analysers conducted on site for 13 problematic sites using locally available expertise. The latest cohort data collected indicates that the average survival rate after initiation of treatment is 70% at 12 months, an improvement from the survival rate of 62.5% reported in 2012. A study is yet to be conducted on causes and underlying factors to “lost to follow-up”.